Merkel cell carcinoma is a rare and aggressive form of neuroendocrine skin cancer. While it accounts for a small fraction of ...

In recent years, cancer researchers have made major breakthroughs by using the body's immune system to fight cancer. One of ...

In this phase 2 study, researchers explored whether fecal microbiota transplant could overcome resistance to immune checkpoint inhibition.

A novel immune checkpoint vaccine induced antigen-specific food allergy tolerance in mice, preventing anaphylaxis. Learn more.

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

A new study has uncovered a hidden step that helps the deadliest malaria parasite survive and multiply inside the human body. Researchers studying Plasmodium falciparum found that the parasite relies ...

A $430,000 National Institute of Health grant was awarded to Dr. Chenshu Liu, on Aug. 1 to support research into meiotic processes, the cellular mechanisms that ensure healthy sex cell development.

Treatment-naive patients with metastatic renal cell carcinoma receive encapsulated fecal microbiota transplants with ...

IFx-2.0, an innate immune agonist, targets resistance to immune checkpoint inhibitors in advanced cutaneous melanoma, receiving FDA orphan drug designation. Phase 1 trials showed IFx-2.0's safety and ...

Biomarker analyses provided proof of a mechanism during combination therapy.Yap and his colleagues observed increased CD8+ T cell infiltration and activation in tumors, reduced the regulatory T ...

The FDA has granted orphan drug designation to IFx-2.0 for patients with stage 2B to stage 4 cutaneous melanoma. The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the ...